1.Shih, JC, Chen, K, Ridd, MJ. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 1999;22:197–217.
2.Brunner, HG, Nelen, M, Breakefield, XO, Ropers, HH, van Oost, BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993;262:578–580.
3.Deckert, J, Catalano, M, Syagailo, YVet al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999;8:621–624.
4.Sabol, SZ, Hu, S, Hamer, D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998;103:273–279.
5.Meyer-Lindenberg, A, Buckholtz, JW, Kolachana, Bet al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 2006;103:6269–6274.
6.Huang, YY, Cate, SP, Battistuzzi, C, Oquendo, MA, Brent, D, Mann, JJ. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 2004;29:1498–1505.
7.Oreland, L, Nilsson, K, Damberg, M, Hallman, J. Monoamine oxidases- activities, genotypes and the shaping of behaviour. J Neural Transm 2007;14:817–822.
8.McDermott, R, Tingley, D, Cowden, J, Frazetto, G, Johnson, DP. Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation. Proc Natl Acad Sci USA 2009;106:2118–2123.
9.Fowler, T, Langley, K, Rice, Fet al. Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity. Psychiatr Genet 2009;19:312–319.
10.Beaver, KM, Delisi, M, Vaughn, MG, Barnes, JC. Monoamine oxidase A genotype is associated with gang membership and weapon use. Compr Psychiatry 2010;51:130–134.
11.Ducci, F, Enoch, MA, Hodgkinson, Cet al. Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry 2008;13:334–347.
12.Tikkanen, R, Ducci, F, Goldman, Det al. MAOA alters the effects of heavy drinking and childhood physical abuse on risk for severe impulsive acts of violence among alcoholic violent offenders. Alcohol Clin Exp Res 2010;34:853–860.
13.Manuck, SB, Flory, JD, Ferrell, REet al. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 2000;95:9–23.
14.Schulze, TG, Muller, DJ, Krauss, Het al. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 2000;96:801–803.
15.Rivera, M, Gutierrez, B, Molina, Eet al. High-acting variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. Am J Med Genet 2008;150B:395–402.
16.Reif, A, Weber, H, Domschke, Ket al. Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet 2012;159B:786–793.
17.Manor, I, Tyano, S, Mel, Eet al. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 2002;7:626–632.
18.Gizer, IR, Ficks, C, Waldman, ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009;126:51–90.
19.Stoltenberg, SF, Christ, CC, Highland, KB. Serotonin system gene polymorphisms are associated with impulsivity in a context dependent manner. Prog Neuropsychopharmacol Biol Psychiatry 2012;39:182–191.
20.Kuepper, Y, Grant, P, Wielpuetz, c, Hennig, j. Maoa-uVNtr genotype predicts interindividual differences in experimental aggressiveness as a function of the degree of provocation. Behav Brain Res 2013;247:73–78.
21.Taylor, A, Kim-Cohen, J. Meta-analysis of gene–environment interactions in developmental psychopathology. Dev Psychopathol 2007;19:1029–1037.
22.Weder, N, Yang, BZ, Douglas-Palumberi, Het al. MAOA genotype, maltreatment, and aggressive behavior: the changing impact of genotype at varying levels of trauma. Biol Psychiatry 2009;65:417–424.
23.Fergusson, DM, Boden, JM, Horwood, LJ, Miller, A, Kennedy, MA. Moderating role of the MAOA genotype in antisocial behaviour. Br J Psychiatry 2012;200:116–123.
24.Kieling, C, Hutz, MH, Genro, JPet al. Gene–environment interaction in externalizing problems among adolescents: evidence from the Pelotas 1993 Birth Cohort Study. J Child Psychol Psychiatry 2013;54:298–304.
25.Frydman, C, Camerer, C, Bossaerts, B, Rangel, A. MAOA-L carriers are better at making optimal financial decisions under risk. Proc R Soc B 2011;278:2053–2059.
26.Chen, H, Pine, DS, Ernst, Met al. The MAOA gene predicts happiness in women. Prog Neuropsychopharmacol Biol Psychiatry 2013;40:122–125.
27.Caspi, A, McClay, J, Moffit, TEet al. Role of genotype in the cycle of violence in maltreated children. Science 2002;297:851–854.
28.Kim-Cohen, J, Caspi, A, Taylor, Aet al. MAOA, maltreatment, and gene–environment interaction predicting children's mental health: new evidence and a metaanalysis. Mol Psychiatry 2006;11:903–913.
29.Sjöberg, RL, Nilsson, KW, Wargelius, HL, Leppert, J, Lindstrom, L, Oreland, L. Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors. Am J Med Genet B Neuropsychiatr Genet 2007;144B:159–164.
30.Åslund, C, Nordquist, N, Comasco, E, Leppert, J, Oreland, L, Nilsson, KW. Maltreatment, MAOA, and delinquency: sex differences in gene–environment interaction in a large population-based cohort of adolescents. Behav Genet 2011;41:262–272.
31.Harro, M, Eensoo, D, Kiive, Eet al. Platelet monoamine oxidase in healthy 9- and 15-years old children: the effect of gender, smoking and puberty. Prog Neuropsychopharmacol Biol Psychiat 2001;25:1497–1511.
32.Tomson, K, Merenäkk, L, Loit, HM, Mäestu, J, Harro, J. The relationship between serotonin transporter gene promoter polymorphism and serum lipid levels at young age in a longitudinal population-representative study. Prog Neuropsychopharmacol Biol Psychiat 2011;35:1857–1862.
33.Reif, A, Kiive, E, Kurrikoff, Tet al. A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology 2011;214:239–248.
34.Kurrikoff, T, Lesch, KP, Kiive, Eet al. Association of a functional variant of the nitric oxide synthase1 gene with personality, anxiety, and depressiveness. Dev Psychopathol 2012;24:1225–1235.
35.Raven, J, Raven, JC, Court, JH. Manual for Raven's Progressive Matrices and Vocabulary Scales. Section 1: General Overview. San Antonio: Harcourt Assessment, 2003.
36.Kiive, E, Kurrikoff, T, Mäestu, J, Harro, J. Effect of alpha2A-adrenoceptor C-1291G genotype and maltreatment on hyperactivity and inattention in adolescents. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:219–224.
37.Kessler, RC, Adler, L, Ames, Met al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35:245–256.
38.Sheehan, DV, Lecrubier, Y, Sheehan, KHet al. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-VI and ICD-10. J Clin Psychiatry 1998;59:22–33.
39.Shlik, J, Aluoja, A, Kihl, E. MINI 5.0.0. Mini rahvusvaheline neuropsühhiaatriline intervjuu DSM-IV. Eesti versioon. 1999.
41.Fan, J, Fossella, J, Sommer, T, Wu, Y, Posner, MI. Mapping the genetic variation of executive attention onto brain activity. Proc Natl Acad Sci U S A 2003;100:7406–7411.
42.Enge, S, Fleischhauer, M, Lesch, KP, Reif, A, Strobel, A. Serotonergic modulation in executive functioning: linking genetic variations to working memory performance. Neuropsychologia 2011;49:3776–3785.
43.Lee, BT, Ham, BJ. Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. Neuroreport 2008;19:515–519.
44.Buckholtz, JW, Callicott, JH, Kolachana, Bet al. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry 2008;13:313–324.
45.Elsky, J, Jonassaint, C, Pluess, M, Stanton, M, Brummett, B, Williams, R. Vulnerability genes or plasticity genes? Mol Psychiatry 2009;14:746–754.
46.Kiive, E, Harro, J. The effect of serotonin transporter gene promoter polymorphism on adolescent and adult ADHD symptoms and educational attainment: a longitudinal study. Eur Psychiatry 2012, doi: 10.1016/j.eurpsy.2012.04.004.
47.Lesch, KP, Bengel, D, Heils, Aet al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527–1531.
48.Hariri, AR, Mattay, VS, Tessitore, Aet al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297:400–403.
49.Harro, J. Inter-individual differences in neurobiology as vulnerability factors for affective disorders: Implications for psychopharmacology. Pharmacol Ther 2010;125:402–422.
50.Harro, J, Kiive, E. Droplets of black bile? Development of vulnerability and resilience to depression in young age. Psychoneuroendocrinology 2011;36:380–392.
51.Kendler, KS. Decision making in the pathway from genes to psychiatric and substance use disorders. Mol Psychiatry 2013;18:640–645.
52.Huisman, J, Santiagop, , Högselius, P, Lemaitre, MJ, Thorm, W. OECD Reviews of Tertiary Education – Estonia. OECD Publications: Paris, France, 2007.
53.Carrel, RJ, Willard, HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005;434:400–404.
54.Laas, K, Reif, A, Kiive, Eet al. A functional NPSR1 gene variant and environment shape personality and impulsive action: a longitudinal study. J Psychopharmacol 2013, doi: 10.1177/0269881112472562.